Brought to you by 
Oncgnostics closes seven-digit Euro million Series A financing
03 Mar 2015
Executive Summary
Cancer diagnostics start-up oncgnostics GMBH closed a Series A financing of seven-digit Euro millions (at the low end Strategic Transactions assumes €1mm ($1mm)). New investor beteiligungsmanagement thüringen GMBH led and was joined by other first-time backers Sparkasse Jena-Saale-Holzland and Anastasia Zepik, and seed shareholders High-tech Gruenderfonds (HTGF) and Stiftung fuer Technologie, Innovation und Forshung Thueringen (STIFT).
Deal Industry
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Oncgnostics closes seven-digit Euro million Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice